Heartflow (HTFL) vs Phreesia (PHR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Heartflow (HTFL) has outperformed Phreesia (PHR) over the past year, gaining 41.1% versus a loss of 55.1%. Heartflow is the larger company by market cap ($4.21 billion vs $645.6 million), about 6.5 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HTFL | PHR |
|---|---|---|
| Share price | $48.46 | $10.40 |
| Market cap | $4.21B | $645.58M |
| 1-day change | -1.82% | -0.95% |
| YTD return | +69.33% | -37.94% |
| 1-year return | +41.07% | -55.15% |
| 5-year return | — | -83.51% |
| P/E ratio (TTM) | — | 61.18 |
| Forward P/E | — | 6.58 |
| EPS (TTM) | $-0.24 | $0.17 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $176.03M | — |
| Revenue growth (YoY) | +39.92% | — |
| Net income (latest FY) | $-116.79M | — |
| Gross margin | 76.80% | — |
| Operating margin | -36.39% | — |
| Net margin | -66.35% | — |
| 52-week high | $54.32 | $24.25 |
| 52-week low | $20.13 | $7.77 |
| Distance from 52-week high | -10.79% | -57.10% |
| Analyst consensus | none | buy |
| Avg. price target upside | -5.08% | +35.28% |
| Average volume | 1.79M | 741.28K |
| Shares outstanding | 86.95M | 62.07M |
| Employees | 843 | 1,789 |
| Sector | Health Care | Consumer Discretionary |
| Industry | Medical/Dental Instruments | Business Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Heartflow is about 6.5 times larger than Phreesia by market value ($4.21B vs $645.58M).
- HTFL has outperformed PHR by 96.2 percentage points over the past year.
- The two companies sit in different sectors: Heartflow in Health Care and Phreesia in Consumer Discretionary.
About Heartflow
HTFL stock →HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries.
Health Care · Medical/Dental Instruments · 843 employees
About Phreesia
PHR stock →Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada.
Consumer Discretionary · Business Services · 1,789 employees
HTFL vs PHR FAQ
Which is bigger, Heartflow or Phreesia?
Heartflow (HTFL) is larger, with a market capitalization of $4.21B compared with $645.58M for Phreesia (PHR).
Which stock has performed better over the past year, HTFL or PHR?
HTFL returned +41.07% over the past 12 months, compared with -55.15% for PHR (price return, excluding dividends). Past performance does not predict future results.
Are Heartflow and Phreesia in the same industry?
No. Heartflow is in the Health Care sector, while Phreesia is in Consumer Discretionary.